Navigation Links
Vibratome 1000, Plus

ProductsVibratome 1000, Plus
Company myNeuroLab.com
Item Vibratome 1000, Plus
Features Inquire
Description The Vibratome 1000 Plus Sectioning System provides a versatile means of sectioning fresh or fixed, animal, or plant tissues. The 1000 employs a vibrating blade principle which allows sectioning without freezing or embedding. The creation of artifacts, the alteration of morphology, the destruction of enzyme activities, and other deleterious effects inherent in freezing or embedding procedures are thus avoided. The Vibratome 1000 Plus has a manual specimen stage advance and semi-automatic blade movement.
Info myNeuroLab.com
Customer Service: (866) 444-0944
Web site: http://www.myneurolab.com

Related medicine products :

1. Vibratome 900 R Closed Loop Water System
2. Vibratome 900R Modular Refrigeration System
3. Vibratome Injector Blades
4. Vibratome Feather Blades
5. Vibratome Instrument Cover
6. Vibratome 1500, Automated
7. Vibratome 3000 Deluxe, Auto./Temp. Controlled
8. Vibratome 3000 Plus, Automated
9. Vibratome 1000, Classic
10. Vibratome 3000 Plus Automated, CE
11. Vibratome 1500, Automated, CE
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...r Ranbaxy Laboratories Limited Friday announced th...a patients//. "Ranbaxy has introduced this product... in HFA (Hydroxy fluoro Alkane: the propellant) ba... in two strengths - Osonide 160mcg and Osonide 80m...
...ceive themselves as being fat, despite being norma...ping depression and school-related stress//, repor...d be due to an inclination to Western culture and ...ful'. The researchers surveyed more than 7000 mid...
...ventis SA announced on Thursday that the US Food a...g Taxotere to treat patients with stomach cancer./... combination with chemotherapy drugs cisplatin and...s that have not been treated with chemotherapy. T...
...the sex clinic only report of failing to get arous... present with just the opposite complaints//. Cont...ring from the so-called persistent sexual arousal ...ut unprovoked feelings of excitement. Currently, ...
Other Medicine News:Health News:Obese Chinese Teens Low On Self-Esteem 2
(Date:9/5/2008)...Newswire-USNewswire/ -- The Florida,Technology, Re...ida,Atlantic University researcher Dr. Herbert Wei...e Center for Molecular Biology and,Biotechnology i...HS,Resources LLC (CHS), $184,294 as part of the St...ce Grant program (SURECAG). SURECAG was,establishe...
(Date:9/5/2008)...ire-FirstCall/ -- CEL-SCI Corporation,(Amex: CVM ... arthritis data,at the Marcus Evans conference on ...y Dr. Daniel Zimmerman, Senior Vice President of R...that CEL-SCI,s rheumatoid,arthritis vaccine CEL-20...,caused by rheumatoid arthritis in an animal model...
(Date:9/5/2008)...RNewswire-USNewswire/ -- A team of,researchers at ...rants from,India and Pakistan take on the habits o... prostate cancer among male immigrants and breast ...e cancer develop due to many reasons, but,environm...hese cancers,",said Jame Abraham, M.D., medical di...
(Date:9/4/2008)... /- Cytopia Limited (ASX:,CYT) today ...Phase Ib/II,study of CYT997, the company,s novel v...ith an aggressive form of brain cancer known as gl...ial is the first Phase II efficacy study in highly... and the second in its,suite of Phase II studies d...
Breaking Medicine Technology:Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 4Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3EUSA Pharma Completes Acquisition Of Cytogen Corporation 5254 1EUSA Pharma Completes Acquisition Of Cytogen Corporation 5254 2EUSA Pharma Completes Acquisition Of Cytogen Corporation 5254 3New Study Demonstrates ACTEMRA 28R 29 28tocilizumab 29 Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2021 1New Study Demonstrates ACTEMRA 28R 29 28tocilizumab 29 Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2021 2New Study Demonstrates ACTEMRA 28R 29 28tocilizumab 29 Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2021 3New Study Demonstrates ACTEMRA 28R 29 28tocilizumab 29 Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2021 4New Study Demonstrates ACTEMRA 28R 29 28tocilizumab 29 Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2021 5Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 18878 1Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 18878 2Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 18878 3Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 18878 4Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies 18878 5Par Pharmaceutical Reports First Quarter 2008 Results 18874 1Par Pharmaceutical Reports First Quarter 2008 Results 18874 2Par Pharmaceutical Reports First Quarter 2008 Results 18874 3Par Pharmaceutical Reports First Quarter 2008 Results 18874 4Par Pharmaceutical Reports First Quarter 2008 Results 18874 5Par Pharmaceutical Reports First Quarter 2008 Results 18874 6Par Pharmaceutical Reports First Quarter 2008 Results 18874 7Par Pharmaceutical Reports First Quarter 2008 Results 18874 8Par Pharmaceutical Reports First Quarter 2008 Results 18874 9Par Pharmaceutical Reports First Quarter 2008 Results 18874 10Par Pharmaceutical Reports First Quarter 2008 Results 18874 11Par Pharmaceutical Reports First Quarter 2008 Results 18874 12